SC 13G/A: Arbutus Biopharma Corp
Ticker: ABUS · Form: SC 13G/A · Filed: 2024-11-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Arbutus Biopharma Corp.
Risk Assessment
Risk Level: low
From the Filing
0001011438-24-000646.txt : 20241114 0001011438-24-000646.hdr.sgml : 20241114 20241114084106 ACCESSION NUMBER: 0001011438-24-000646 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 GROUP MEMBERS: SINA TOUSSI GROUP MEMBERS: TWO SEAS CAPITAL GP LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980597776 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85963 FILM NUMBER: 241457436 BUSINESS ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Two Seas Capital LP CENTRAL INDEX KEY: 0001823138 ORGANIZATION NAME: IRS NUMBER: 843799363 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 32 ELM PLACE, 3RD FLOOR CITY: RYE STATE: NY ZIP: 10580 BUSINESS PHONE: 917.536.6028 MAIL ADDRESS: STREET 1: 32 ELM PLACE, 3RD FLOOR CITY: RYE STATE: NY ZIP: 10580 FORMER COMPANY: FORMER CONFORMED NAME: Kairos Capital Management LP DATE OF NAME CHANGE: 20200831 SC 13G/A 1 form_sc13ga-arbutus.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)*   _____________________________________ Arbutus Biopharma Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 03879J100 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d)   * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 03879J100                 (1)    Name of Reporting Persons:   Two Seas Capital LP   (2)   Check the Appropriate Box if a Member of a Group (See Instructions): (a)  ☐        (b)  ☐     (3)   SEC Use Only:     (4)   Citizenship or Place of Organization:   Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:        (5)     Sole Voting Power   8,387,388      (6)    Shared Voting Power   0      (7)    Sole Dispositive Power   8,387,388      (8)    Shared Dispositive Power   0 (9)   Aggregate Amount Beneficially Owned by Each Reporting Person:   8,387,388 (10)   Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See